A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients

PHASE4

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped Trial will not complete until at least 2025 and evolution of immunosuppressant therapy has made it unlikely that patients will convert from Modigraf to Prograf.

Conditions

Heart Transplantation
Kidney Transplantation
Liver Transplantation

Interventions

DRUG: Tacrolimus granules
DRUG: Tacrolimus capsules

Sponsor

Astellas Pharma Europe Ltd.